HIV Antibody Characterization as a Method to Quantify Reservoir Size During Curative Interventions

被引:47
作者
Burbelo, Peter D. [1 ]
Bayat, Ahmad [2 ]
Rhodes, Craig S. [3 ]
Hoh, Rebecca [4 ]
Martin, Jeffrey N. [4 ,5 ]
Fromentin, Remi [6 ]
Chomont, Nicolas [6 ]
Huetter, Gero [7 ]
Kovacs, Joseph A. [8 ]
Deeks, Steven G. [4 ]
机构
[1] NIDCR, Clin Dent Res Core, Bethesda, MD 20892 USA
[2] NIH, Dept Perioperat Med, Ctr Clin, Bethesda, MD 20892 USA
[3] Natl Inst Dent & Craniofacial Res, Lab Dev Biol, San Francisco, CA USA
[4] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[5] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[6] Vaccine & Gene Therapy Inst Florida, Port St Lucie, FL USA
[7] Heidelberg Univ, Inst Transfus Med & Immunol, Mannheim, Germany
[8] NIH, Crit Care Med Dept, NIH Clin Ctr, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
antibodies; elite controllers; HIV-1; persistence; serology; viral reservoirs; INFECTION; THERAPY; QUANTIFICATION; REPLICATION; PERSISTENCE;
D O I
10.1093/infdis/jit667
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Quantitative humoral profiling of recent samples from a human immunodeficiency virus (HIV)-infected adult who was cured following a delta32/delta32 CCR5 stem cell transplant in 2007 revealed no antibodies against p24, matrix, nucleocapsid, integrase, protease, and gp120, but low levels of antibodies against reverse transcriptase, tat, and gp41. Antibody levels to these HIV proteins persisted at high and stable levels in most noncontrollers, elite controllers, and antiretroviral-treated subjects, but a rare subset of controllers had low levels of antibodies against matrix, reverse transcriptase, integrase, and/or protease. Comprehensive HIV antibody profiles may prove useful for monitoring curative interventions.
引用
收藏
页码:1613 / 1617
页数:5
相关论文
共 15 条
[1]   Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation [J].
Allers, Kristina ;
Huetter, Gero ;
Hofmann, Joerg ;
Loddenkemper, Christoph ;
Rieger, Kathrin ;
Thiel, Eckhard ;
Schneider, Thomas .
BLOOD, 2011, 117 (10) :2791-2799
[2]   Duration of humoral immunity to common viral and vaccine antigens [J].
Amanna, Ian J. ;
Carlson, Nichole E. ;
Slifka, Mark K. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (19) :1903-1915
[3]   The implications of viral reservoirs on the elite control of HIV-1 infection [J].
Buckheit, Robert W., III ;
Salgado, Maria ;
Martins, Karen O. ;
Blankson, Joel N. .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2013, 70 (06) :1009-1019
[4]   Rapid antibody quantification and generation of whole proteome antibody response profiles using LIPS (luciferase immunoprecipitation systems) [J].
Burbelo, Peter D. ;
Ching, Kathryn H. ;
Mattson, Thomas L. ;
Light, Jason S. ;
Bishop, Lisa R. ;
Kovacs, Joseph A. .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 352 (04) :889-895
[5]   HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation [J].
Chomont, Nicolas ;
El-Far, Mohamed ;
Ancuta, Petronela ;
Trautmann, Lydie ;
Procopio, Francesco A. ;
Yassine-Diab, Bader ;
Boucher, Genevieve ;
Boulassel, Mohamed-Rachid ;
Ghattas, Georges ;
Brenchley, Jason M. ;
Schacker, Timothy W. ;
Hill, Brenna J. ;
Douek, Daniel C. ;
Routy, Jean-Pierre ;
Haddad, Elias K. ;
Sekaly, Rafick-Pierre .
NATURE MEDICINE, 2009, 15 (08) :893-U92
[6]   AIDS - Re-emergence of HIV after stopping therapy [J].
Chun, TW ;
Davey, RT ;
Engel, D ;
Lane, HC ;
Fauci, AS .
NATURE, 1999, 401 (6756) :874-875
[7]   Quantification of latent tissue reservoirs and total body viral load in HIV-1 Infection [J].
Chun, TW ;
Carruth, L ;
Finzi, D ;
Shen, XF ;
DiGiuseppe, JA ;
Taylor, H ;
Hermankova, M ;
Chadwick, K ;
Margolick, J ;
Quinn, TC ;
Kuo, YH ;
Brookmeyer, R ;
Zeiger, MA ;
BarditchCrovo, P ;
Siliciano, RF .
NATURE, 1997, 387 (6629) :183-188
[8]   Towards an HIV cure: a global scientific strategy [J].
Deeks, Steven G. .
NATURE REVIEWS IMMUNOLOGY, 2012, 12 (08) :607-614
[9]   Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies [J].
Eriksson, Susanne ;
Graf, Erin H. ;
Dahl, Viktor ;
Strain, Matthew C. ;
Yukl, Steven A. ;
Lysenko, Elena S. ;
Bosch, Ronald J. ;
Lai, Jun ;
Chioma, Stanley ;
Emad, Fatemeh ;
Abdel-Mohsen, Mohamed ;
Hoh, Rebecca ;
Hecht, Frederick ;
Hunt, Peter ;
Somsouk, Ma ;
Wong, Joseph ;
Johnston, Rowena ;
Siliciano, Robert F. ;
Richman, Douglas D. ;
O'Doherty, Una ;
Palmer, Sarah ;
Deeks, Steven G. ;
Siliciano, Janet D. .
PLOS PATHOGENS, 2013, 9 (02)
[10]   Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy [J].
Finzi, D ;
Blankson, J ;
Siliciano, JD ;
Margolick, JB ;
Chadwick, K ;
Pierson, T ;
Smith, K ;
Lisziewicz, J ;
Lori, F ;
Flexner, C ;
Quinn, TC ;
Chaisson, RE ;
Rosenberg, E ;
Walker, B ;
Gange, S ;
Gallant, J ;
Siliciano, RF .
NATURE MEDICINE, 1999, 5 (05) :512-517